DCF — EMERSON HOSPITAL
Enterprise Value: $-505.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-505.0M
Enterprise Value
$-160.1M
PV of Cash Flows
$-345.0M
PV of Terminal Value
$-555.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $324.6M | $-31.3M | -10.0% | $-45.0M | $-41.0M |
| Year 2 | $334.3M | $-28.9M | -9.0% | $-43.1M | $-35.6M |
| Year 3 | $344.4M | $-26.3M | -8.0% | $-40.9M | $-30.7M |
| Year 4 | $354.7M | $-25.3M | -7.0% | $-40.4M | $-27.6M |
| Year 5 | $365.3M | $-25.2M | -7.0% | $-40.7M | $-25.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-505.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$315.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1014467372568908
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5